LATEST PRESS RELEASES

133 views4 min read

Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial

Bright Minds Biosciences
Bright Minds BiosciencesVANCOUVER, British Columbia, March 14, 2022 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced the successful completi... Read More...
42 views6 min read

Red Light Holland and Advocacy Group Psychedelic Medicine Alliance Washington Celebrate the Success of their Collaboration as Washington Legislature Funds Psilocybin Wellness Workgroup

Red Light Holland
● Washington legislators fund $200,000 USD for a Psilocybin Wellness Workgroup to research and write a report that will inform a pathway for future legislation.● The workgroup will include a member of the Psychedelic Medicine Alliance of Washington as well as other community, health care, and regulatory representatives.Toronto, Ontario--(... Read More...
48 views2 min read

Novamind Grants Restricted Share Units

Novamind
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.TORONTO, ON / ACCESSWIRE / March 11, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psych... Read More...
1281 views5 min read

Pure Extracts Technologies Corp. Closes Special Warrant Offering and Debt Settlement and Grants Options

Pure Extracts Technologies
Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, March 08, 2022 -- Pure Extracts Technologies Corp. (“Pure Extracts” or the “Company”) (CSE: PULL) (XFRA: A2QJAJ) is plea... Read More...
1405 views3 min read

Optimi Health Announces Investor Relations Agreement

Optimi Health
VANCOUVER, British Columbia, March 08, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to announce it has entered into agreements with Kydde... Read More...
50 views4 min read

Bright Minds Biosciences to Present at the Oppenheimer 32nd Annual Healthcare Conference

Bright Minds Biosciences
VANCOUVER, British Columbia, March 08, 2022 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Company management will present virtually ... Read More...
133 views4 min read

Mydecine To Attend March Investor Conferences

Mydecine Innovations Group
DENVER, March 03, 2022 -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced the company will be attending three conferences for investors in March – the 34th Annual Roth Conf... Read More...
113 views8 min read

Allied Corp Supports Veteran Focused National Organization “Tac-tical Games” as Platinum Sponsor

Allied
Allied Corp.KELOWNA, British Columbia., March 01, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce its support of the veterans organization Tactical Games. The Tactical Games organization provides multiple events across the US for veterans and athletes to sharpen their tactical skills while competing i... Read More...
1035 views4 min read

Optimi Health Upgrades Trading to the OTCQX Best Market

Optimi Health
Optimi Health Corp.VANCOUVER, British Columbia, March 01, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to announce the upgrade of its com... Read More...
936 views8 min read

Conor McGregor Brings TIDL Sport Next Generation Recovery Products to the Netherlands in an Exclusive Partnership with Red Light Holland

Red Light Holland
Toronto, Ontario--(Newsfile Corp. - February 28, 2022) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation is pleased to announce its wholly owned subsidiary SR Wholesale in the Netherlands ("SR Wholesale"), has signed an exclusive distribution deal with C... Read More...
816 views6 min read

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

Numinus Wellness
VANCOUVER, BC, Feb. 28, 2022 - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting"), held earli... Read More...
1191 views4 min read

Lobe Sciences Ltd. Strengthens Its Balance Sheet

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (the "Acquiror") announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 22, 2022 and February 23, 2022, it sold a total of 4,500,000 common shares in the capital of Ionic Bra... Read More...
126 views6 min read

Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements

Optimi Health
Optimi Health Corp.--B.C. company brings highest quality fruiting body mushroom formulations to the Canadian nutraceutical marketVANCOUVER, British Columbia., Feb. 22, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and... Read More...
123 views3 min read

Novamind Publishes Psychedelic Therapy Patient Case Studies

Novamind
TORONTO, ON / ACCESSWIRE / February 22, 2022 / Novamind Inc.(CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, today launched Healing Stories, a series of case studies with first-hand accounts of patient experiences with psychedelic-assisted psychotherapy at Novamind clinics (... Read More...
128 views8 min read

Allied Corp Commends the Colombian Government for Passing Regulations that Advance the Export of Dried Cannabis Flower From Colombia

Allied
Allied Corp.KELOWNA, British Columbia., Feb. 22, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to commend the Colombian Government for passing Regulation 227 (the "Regulation") on February 20, 2022, which aims to enable the export of cannabis flower from Colombia.On July 23, 2021 the President of Colombia, Pres... Read More...
1173 views5 min read

UPDATE – Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements

Optimi Health
VANCOUVER, British Columbia., Feb. 22, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to announce the official launch of its line of functi... Read More...
123 views4 min read

Lobe Sciences Ltd. Strengths Its Balance Sheet

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - February 16, 2022) - Lobe Sciences Ltd. (the "Acquiror") announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 15, 2022, it sold 5,800,000 common shares in the capital of Ionic Brands Corp. (the "Issuer" and the common shares of the Issuer ... Read More...
64 views5 min read

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program

Optimi Health
Optimi Health Corp.VANCOUVER, British Columbia, Feb. 16, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to report that Health Canada has ad... Read More...
118 views5 min read

Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

Mydecine Innovations Group
DENVER, Feb. 16, 2022 -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced the inclusion of a novel molecule with potentially heart-safe microdose enabling properties in thei... Read More...
Financials120 views29 min read

Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update

Field Trip Health
Earned patient services revenues of $1,360,811, an increase of 50% over the prior quarter and 330% year over year.At December 31, 2021, Field Trip had approximately $74.5 million in unrestricted cash and cash equivalents and short-term investments.Received Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate)... Read More...
317 views4 min read

Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation

Revive Therapeutics
TORONTO, Feb. 15, 2022 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food and Drug Administration ("FDA") has granted Orph... Read More...
104 views4 min read

MINDCURE Announces Strategic Review

Mind Cure Health
Independent Special Committee Formed VANCOUVER, BC, Feb. 10, 2022 - Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in advanced proprietary technology for mental health care and research in psychedelics, announced today its Board of Directors has formed a special committee (the "Special Committee") of in... Read More...
119 views3 min read

Novamind Appoints Prakash Gowd as Chief Operating Officer

Novamind
TORONTO, ON / ACCESSWIRE / February 8, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that Prakash Gowd has been appointed as the Company's Chief Operating Officer (COO), replacing Pierre Bou-Mansour who is leaving the Company th... Read More...
764 views6 min read

Optimi Health Dealer’s License Granted by Health Canada

Optimi Health
Optimi Health to become a global leader in all-natural psilocybin productionVANCOUVER, British Columbia, Feb. 07, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellne... Read More...
861 views4 min read

Psyence Awarded ISO Certification through the British Standards Institute for its Natural Psilocybin Production Facility

Psyence Group
TORONTO, Feb. 07, 2022 -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that its ISO22000 graded Psilocybin production facility has officially received International Organiza... Read More...
56 views7 min read

MINDCURE Hires Dr. Clare Purvis from Headspace to the position of Chief Product Officer to Advance Mental Health Digital Therapeutics Platform

Mind Cure Health
VANCOUVER, BC, Feb. 3, 2022 - Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in advanced proprietary technology for mental health care and research in psychedelics, announced today the hiring of Dr. Clare Purvis, formerly Headspace Inc.'s Vice President of Clinical Product and Content Development, for t... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!